111In-LLP2A-DOTA Polyethylene Glycol-Targeting {alpha}4{beta}1 Integrin: Comparative Pharmacokinetics for Imaging and Therapy of Lymphoid Malignancies.
about
In-vivo biodistribution and safety of 99mTc-LLP2A-HYNIC in canine non-Hodgkin lymphomaHigh-Throughput Approaches to the Development of Molecular Imaging Agents.Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of diseaseAffinity of the alpha4-beta1 integrin-targeting peptide LLP2A to canine lymphoma.New radiotracers for imaging of vascular targets in angiogenesis-related diseases.Characterization and evaluation of (64)Cu-labeled A20FMDV2 conjugates for imaging the integrin αvβ 6Integrin targeted delivery of radiotherapeutics.Halogenated benzimidazole carboxamides target integrin alpha4beta1 on T-cell and B-cell lymphomas.Tumor-targeting peptides from combinatorial libraries.Chemically programmed bispecific antibodies that recruit and activate T cellsManaging lymphoma with non-FDG radiotracers: current clinical and preclinical applications.A practical guide to the construction of radiometallated bioconjugates for positron emission tomography.Tracking stem cells in tissue-engineered organs using magnetic nanoparticles.Mini-PEG spacering of VAP-1-targeting 68Ga-DOTAVAP-P1 peptide improves PET imaging of inflammation.Comparison of two cross-bridged macrocyclic chelators for the evaluation of 64Cu-labeled-LLP2A, a peptidomimetic ligand targeting VLA-4-positive tumors."One-Pot" Fabrication of Highly Versatile and Biocompatible Poly(vinyl alcohol)-porphyrin-based Nanotheranostics.Comparative Assessment of Complex Stabilities of Radiocopper Chelating Agents by a Combination of Complex Challenge and in vivo Experiments.
P2860
Q27305229-2F992587-43F9-4101-8494-B950F9935829Q30275493-9B55BDEC-8AE8-4125-BEA0-D1D93DECAC0CQ33870879-4B0053DD-5235-4AD4-9B2E-9696D63AEDEFQ34158053-78A23B4E-64A6-44A0-8706-7C017CAE7F2FQ34216877-0CF276A4-D732-420D-8F8D-9E343B4F8161Q34778502-61867B11-70B4-4B42-9C6B-A1425337E369Q34912696-CAB208F4-6850-452F-89AA-EEF9FAE97AB0Q35194110-23057D69-7F03-49EA-8015-AB81C2A07AB9Q36025723-51F99FA3-CA27-484D-855C-89864AAB73B6Q36217175-B57FE357-ACFF-49E4-A625-5EDEA3657A75Q36948431-BBDEA546-608C-432E-B5A6-BA910A81303EQ37172093-84B80DED-2193-4736-B32C-B6EC45732671Q38151018-80F3C5F4-7003-4470-B55B-201DD4596069Q40157730-EC06B751-31C8-40D2-82E7-87B49B105565Q43146841-1B99F328-995A-4773-8D56-E7F75BE8E3E2Q43273036-311BE704-FA7B-48EA-88F2-07155B383621Q53676991-2F03D9D6-B384-4D96-89D0-FF07411146E2
P2860
111In-LLP2A-DOTA Polyethylene Glycol-Targeting {alpha}4{beta}1 Integrin: Comparative Pharmacokinetics for Imaging and Therapy of Lymphoid Malignancies.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
111In-LLP2A-DOTA Polyethylene ...... rapy of Lymphoid Malignancies.
@en
111In-LLP2A-DOTA Polyethylene ...... rapy of Lymphoid Malignancies.
@nl
type
label
111In-LLP2A-DOTA Polyethylene ...... rapy of Lymphoid Malignancies.
@en
111In-LLP2A-DOTA Polyethylene ...... rapy of Lymphoid Malignancies.
@nl
prefLabel
111In-LLP2A-DOTA Polyethylene ...... rapy of Lymphoid Malignancies.
@en
111In-LLP2A-DOTA Polyethylene ...... rapy of Lymphoid Malignancies.
@nl
P2093
P1476
111In-LLP2A-DOTA Polyethylene ...... erapy of Lymphoid Malignancies
@en
P2093
Arutselvan Natarajan
Huguette Albrecht
Julie L Sutcliffe
Riccardo Ferdani
Sally J Denardo
Simon R Cherry
P304
P356
10.2967/JNUMED.108.056903
P407
P577
2009-03-16T00:00:00Z